Early data from US biotech Moderna has revealed that its Covid-19 vaccine candidate is 94.5 per cent effective, raising hopes that a range of immunisations will be available to help end the pandemic. The interim analysis of the vaccine, currently known as mRNA-1273, comes after 95 trial participants contracted Covid-19, including just five who were given the coronavirus jab. While the data was published via a press release, it includes significant details that remain unclear around the Pfizer-BioNTech vaccine – which uses the same mRNA technology to target the coronavirus spike protein and an immune response.
Tag Archives: SARS-Cov-2
Pfizer’s Covid-19 Vaccine Is 90% Effective, But Has Storage & Shipping Issues
Work to distribute Pfize and BioNTech’s COVID-19 vaccine is gearing up but it won’t hit local pharmacies for the general public any time soon.
Covid-19 Podcasts: ‘Costs Of A Winter Lockdown To Take Cases To Zero’
Countries like the United Kingdom and France are locking down amid a spike in cases. They’re concerned that winter will only make things worse. But if Europe and America want to see an example of how well lockdowns work during colder months, they need only look at Melbourne, Australia.
The country’s second-largest city went through two lockdowns – one of which happened during its winter. Remarkably, the city has reported no new cases since late October. But, Jason Gale reports, it has come at a cost.
Interview: Anthony Fauci On Covid-19 (JAMA Video)
Anthony S. Fauci, MD returns to JAMA’s Q&A series to discuss the latest developments in the COVID-19 pandemic, including the continued importance of nonpharmaceutical interventions (masking, handwashing, physical distancing) for managing rising case numbers in the US and globally.
Recorded October 28, 2020.
Topics discussed in this interview: 0:00 Introduction 0:20 NAM Presidential Citation for Exemplary Leadership 1:19 COVID-19 numbers and excess deaths 4:05 National masking mandate 5:55 How to get people to accept masking 7:07 Herd Immunity and the Great Barrington Declaration 9:51 The holidays and airplane travel 13:44 Therapies update 17:54 Vaccines update 20:08 Vaccine distribution 22:00 Vaccine safety 24:42 How Australia has dealt with COVID-19 spikes 27:00 Acknowledgements and baseball
Covid-19 Videos: ‘Tracking President Trump’s Travels Over Seven Days’ (WSJ)
President Trump’s schedule in the week before he was diagnosed with Covid-19 included a Rose Garden event, a presidential debate, and visits to three states.
Photo: Getty Images
Morning News Podcast: President Trump Tests Positive For Covid-19, Stimulus Bill Update
OvernightPresident Trump and First Lady Melania Trump announced that they have tested positive for the coronavirus. In a statement shortly thereafter, the White House physician said the Trumps “are both well at this time” and will remain at home.
The president is 74 years old, which generally puts him at higher risk for severe illness from the virus, according to CDC guidelines.
- Plus, the latest on the stimulus bill
- And, big tech has become a bipartisan punching bag.
Guests: Axios’ Sam Baker, Alayna Treene and Ashley Gold.
TOP JOURNALS: RESEARCH HIGHLIGHTS FROM SCIENCE MAGAZINE (Oct 2, 2020)
TOP JOURNALS: RESEARCH HIGHLIGHTS FROM SCIENCE MAGAZINE (SEPT 25, 2020)
Research:”The Costs Of A Covid-19 Vaccine” (Video)
As government and private money pour into the global race for a Covid-19 vaccine, drugmakers are under great pressure to keep the shot affordable while also keeping investors happy. WSJ explains what this means for the final price tag of the jabs.
Illustration: Crystal Tai
Covid-19 Infographics: “Riskiest Activities, How Contagious & Deadly It Is”
Boomers Daily 